Mounjaro on NHS Criteria: What You Need to Know

Mounjaro is a prescription-only medicine — its active substance, tirzepatide, is a dual GIP and GLP-1 receptor agonist used in the management of weight in adults when prescribed by a qualified clinician. In the UK, NHS prescribing of Mounjaro for weight management is subject to specific commissioning criteria set at a national or regional level, meaning it is not automatically available to everyone who might benefit from it.

What Criteria Typically Involve

Published NHS guidance for Mounjaro in weight management has generally referenced factors such as body mass index (BMI), the presence of at least one weight-related health condition, and whether the person is being supported through a specialist weight management service. The precise criteria can vary depending on where you are in the country and which NHS body is responsible for commissioning the service. Your prescriber or doctor is the right person to assess whether you qualify under the current guidance applicable to your area.

For authoritative detail on current NHS criteria, the NHS England website and the electronic Medicines Compendium hold the most up-to-date published information — but your clinical team will interpret this in the context of your own health history.

Private Prescribing Is a Separate Route

Mounjaro is also available through private prescribers and registered pharmacies in many countries, under separate arrangements from any national health service. Whether accessed via a public or private route, it remains a prescription-only medicine, and the prescription decision rests with a qualified clinician. GLP Trackr does not sell, supply, or source medication through either route.

If you have questions about whether you can get Mounjaro on the NHS, your prescriber or a specialist weight management service is the right place to start. You can also read more about how Mounjaro is used within NHS settings for broader context, or explore the specific NHS eligibility criteria for Mounjaro in more detail.

Once you have been prescribed Mounjaro — however you accessed that prescription — staying consistent and informed matters. GLP Trackr is a companion app built specifically for people already taking Mounjaro or Wegovy, and its dose-logging feature is the most direct way to make sure nothing slips through the cracks.

Logging each injection in the app — date, dose strength, and time — gives you a clear record of your treatment history. If you are being reviewed by a specialist service (as is common with NHS-prescribed weight management programmes), the doctor report feature lets you bring a clear summary of your journey to those appointments: weight trends, side-effect patterns, and dose history all in one place. That kind of structured record can make review conversations far more useful.

The weekly progress tracking — weight logs, measurements, and check-ins — also helps you see the fuller picture beyond the scale, which is especially valuable when your ongoing access to the medication may depend on demonstrating progress within a structured programme.

For more on the cost and access landscape, the Mounjaro cost and access overview covers the broader picture in informational terms.

Any questions about your specific eligibility, dose, or ongoing prescription should always go to your prescriber or doctor — they know your full clinical history and the criteria that apply in your area. GLP Trackr is here to help you track and support the journey, not to replace that guidance.

Ready to make your treatment easier to stay on top of? GLP Trackr is free to try for seven days — available now on the App Store and Google Play.